期刊文献+

hTRX-PR39融合基因cDNA克隆的构建及鉴定 被引量:2

Construction and identification of recombinant plasmids expressing hTRX-PR39
原文传递
导出
摘要 目的研究人硫氧还蛋白(hTRX)和抗菌肽PR39基因在脑缺血疾病治疗中的作用,构建hTRX-PR39cDNA融合基因。方法设计合成PR39、hTRX正向和反向引物,采用PCR方法,扩增获得两端具有BamHI和Ecor721、Eco721和EcoI酶切位点的PR39 cDNA和hTRXcDNA片段,并分别克隆到pGEM-Teasy中,转化细菌,筛选阳性克隆,酶切鉴定并测序。BamHI和EcoR721双酶切pGEM-T-hTRX和pGEM-T-PR39,将获取的PR39/BamHI,EcoR721片段克隆到pGEM-T-hTRX/BamHI,EcoR721载体中,构建pGEM-T-hTRX-PR39载体。结果经DNA测序证实,修饰过的hTRXcDNA、PR39 cDNA片段的核酸序列和推导的氨基酸同数据库资料一致。重组质粒pGEM-T-hTRX-PR39酶切图谱证实hTRX-PR39融合肽cDNA已克隆到pGEM-T表达载体中。结论成功克隆出具有EcoR721和EcoRI、BamHI和EcoR721酶切位点的hTRXcDNA和PR39 cDNA片段,并构建pGEM-T-hTRX-PR39载体。 Objective To explore the effects of hTRX and PR39 as target genes on cerebral ischemic disease, and to construct a fusion gene of hTRX-PR39 cDNA. Methods The forward and reverse primers of PR39 were designed and synthesized. By means of PCR, the fragment encoding PR39 was gained, including EcoR721 and BamH I restriction enzyme sites, and the new hTRX cDNA including EcoR721 and EcoRI restriction enzyme sites was also gained. Then the synthesized fragments were easily cloned into vector pGEM-T. The positive clone was identified by restriction enzymes, and then the cloned amplified fragments were sequenced by the dideoxy-mediated chain-termination method. The cloned hTRX and PR39 cDNA were compared with the GeneBank sequence by the DNASIS. After pGEM-T-hTRX and pGEM-T-PR39 were both digested by BamH I and EcoRI, the PR39/BamHI, EcoRI was cloned into the recombinant vector pGEM-T-hTRX/BamHI, EcoRl . The recombinant vector pGEM-T- hTRX-PR39 was gained. Results Sequences of modified hTRX and PR39 were consistent with those of the gene bank. After analyzing the ORF of the cloned hTRX-PR39 cDNA by the DNASIS, we found that amino acids encoded by the cloned hTRX-PR39 cDNA were identical to published results. Conclusion The sequence of hTRX including EcoR721 and EcoRI restriction enzyme sites and sequence of PR39 including EcoR721 and BamH I restriction enzyme sites were successfully obtained by PCR. Also, the recombinant vector pGEM-T-hTRX-PR39 was successfully constructed.
出处 《山东大学学报(医学版)》 CAS 北大核心 2009年第3期30-34,42,共6页 Journal of Shandong University:Health Sciences
关键词 脑缺血 硫氧还蛋白 基因融合 抗菌肽PR39 Brain ischemia Thioredoxin gene fusion Antibacterial peptide PR39
  • 相关文献

参考文献8

  • 1Powis G, Montfort W R. Properties and biological activities of thioredoxins[J]. Annu Rev Biophys Biomol Struct, 2001, 30: 421-455.
  • 2Spector A, Yan G Z, Huang R R, et al. The effect of H202 upon thioredoxin-enriched lens epithelial cells[ J]. Biol Chem, 1988, 263(10) :4984-4990.
  • 3Saitoh M, Nishitoh H, Fujii M, et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase(ASK) 1 [J]. EMBO J, 1998,17(9) :2596-2606.
  • 4Gaczynska M,Osmulski P A,Gao Y,et al. Proline-and argininerich pepfides constitute a novel class of allosteric inhibitors of proteasome activity [ J ]. Biochemistry, 2003, 42 ( 29 ) : 8663- 8670.
  • 5Anbanandam A, Albarado D C, Tirziu D C, et al. Molecular basis for proline-and arginine-rich peptide inhibition of proteasome[J]. J Mol Biol, 2008, 384(1):219-227.
  • 6Muinck E D, Nagy N, Tirziu D, et al. Protection against myocardial ischemia-reperfusion injury by the angiogenic Masters-witch protein PR 39 gene therapy: the roles of HIFlalpha stabilization and FGFR1 signaling [ J ]. Antioxid Redox Signal, 2007, 9(4) :437--445.
  • 7Wu J, Parungo C, Wu G, et ai. PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2 [J]. Circulation, 2004, 109(13):1660-1667.
  • 8Colas P, Cohen B, Jessen T, et al. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase-2[J]. Nature, 1996, 380(6574):548-550.

同被引文献15

  • 1ZHANG G, ROSS C R, BLECHA F. Porcine antimicrobial pep-tides: new prospects for ancient molecules of host defense[ J]. VetRes,2000, 31(3); 277 -296.
  • 2HOFFMEYER M R, SCALIA R, ROSS C R, et al. PE-39, a po-tent neutrophil inhibitor, attenuates myocardial ischefnia - reperfu-sion injury in mice[ J]. Am J Physiol Heart Circ Physiol,2000,279(6): H2824-H2828.
  • 3POST M J, SATO K, MURAKAMI M, et al. Adenoviral PR39 im-proves blood flow and myocardial function in a pig model of chronicmyocardial ischemia by enhancing collateral formation[ J]. Am JPhysiol Regul Integr Comp Physiol,2006 , 290(3) : R494 - R500.
  • 4VELDHUIZEN E J,SCHNEIDER V A,AGUSTIANDARI H, etal.Antimicrobial and immunomodulatory activities of PR - 39 derivedpeptides[J]. PLoS One,2014, 9(4) : e95939.
  • 5AGERBERTH B, LEE J Y, BERGMAN T, et al. Amino acid se-quence of PH -39. Isolation from pig intestine of a new member ofthe family of proline - arginine - rich antibacterial peptides [ J].Eur J Biochem, 1991, 202(3); 849 -854.
  • 6N1ZET V,OHTAKE T,LAUTH X,et al. Innate antimicrobial pep-tide protects the skin from invasive bacterial infection [ J ]. Nature,2001, 414(6862) : 454 -457.
  • 7HENNIG-PAUKA I,KOCH R, HOELTIG D,et al. PR-39, aporcine host defence peptide,is prominent in mucosa and lymphatictissue of the respiratory tract in healthy pigs and pigs infected withActinobacillus pleuropneumoniae[ J]. BMC Res Notes,2012(5):539.
  • 8TIAN W, U B, ZHANG X,et al. Suppression of tumor invasionand migration in breast cancer cells following delivering of siRNA a-gainst Stat3 with the antimicrobial peptide PR39[ J]. Oncol Rep,2012,28(4):1362-1368.
  • 9扈进冬,吴远征,杨合同.猪PR-39基因的克隆及在大肠杆菌中的串联表达载体的构建[J].中国畜牧兽医,2008,35(12):56-59. 被引量:3
  • 10朱勇军,翁玄,张健,文阳安.抗菌肽PR-39真核表达载体的构建及表达检测[J].重庆医科大学学报,2009,34(12):1643-1645. 被引量:4

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部